A field effect transistor modified with reduced graphene oxide for immunodetection of Ebola virus
- 46 Downloads
The authors describe a field effect transistor (FET) based immunoassay for the detection of inactivated ebola virus (EBOV). An equine antibody against the EBOV glycoprotein was immobilized on the surface of the FET that was previously modified with reduced graphene oxide (RGO). The antibody against EBOV was immobilized on the modified FET, and the response to EBOV was measured as a function of the shift of Dirac voltage. The method can detect the EBOV over the concentration range from 2.4 × 10−12 g·mL−1 to 1.2 × 10−7 g·mL−1 and with a limit of detection as low as 2.4 pg·mL−1. The assay has satisfactory specificity and was applied to the quantitation of inactivated EBOV in spiked serum.
KeywordsEbola virus Field effect transistor Biosensor Sensitive detection Reduced graphene oxide Immunoreaction
This work was supported by the National Natural Science Foundation of China (Nos. 21475034, 21675041, and 61390504).
Compliance with ethical standards
The author(s) declare that they have no competing interests. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
- 8.Ikegami T, Saijo M, Niikura M, Miranda ME, Calaor AB, Hernandez M, Manalo DL, Kurane I, Yoshikawa Y, Morikawa S (2013) Development of an immunofluorescence method for the detection of antibodies to Ebola virus subtype Reston by the use of recombinant nucleoprotein-expressing HeLa cells. Microbiol Immunol 46:633–638CrossRefGoogle Scholar
- 9.Drosten C, Gottig S, Schilling S, Asper M, Panning M, Schmitz H, Gunther S (2002) Rapid detection and quantification of RNA of ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, rift valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol 40:2323–2330CrossRefGoogle Scholar
- 12.van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P, Baize S, Horby PW, Raoul H, Magassouba N, Antierens A, Lomas C, Faye O, Sall AA, Fransen K, Buyze J, Ravinetto R, Tiberghien P, Claeys Y, De Crop M, Lynen L, Bah EI, Smith PG, Delamou A, De Weggheleire A, Haba N (2016) Evaluation of convalescent plasma for ebola virus disease in Guinea. N Engl J Med 374:33–42CrossRefGoogle Scholar